FILANA THERAPEUTICS INC
SAVA·14817C107·US·Common Stock·Healthcare - Biotechnology-13D/G
SAVA (FILANA THERAPEUTICS INC) is held by 58 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($2.4M), TWO SIGMA INVESTMENTS, LP ($2M), MARSHALL WACE, LLP ($1.9M). Net institutional sentiment: Mixed.
58
Holders
(3 Elite)
$13.7M
Total Value
36% (64)
Consensus
23 buying - 41 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Mar 3, 2026 · Insiders Nov 25, 2025 · Activists Jul 29, 2025 · Congress none
InsiderAJAnderson Robert Eugene JrBuy $25KNov 24, 2025
InsiderBRBarry RichardBuy $414KNov 20, 2025
InsiderBRBarry RichardBuy $202KNov 19, 2025
Checking access…
Top Holders
Checking access…
Showing 1-20 of 70
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $667.3B
413 holders · $186.4B
394 holders · $391.5B
392 holders · $97.1B
391 holders · $127.1B
391 holders · $147.4B
389 holders · $77B
385 holders · $209.1B
381 holders · $255.1B
380 holders · $129.4B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer